308 related articles for article (PubMed ID: 32557716)
21. Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates.
Mulubwa M; Griesel HA; Mugabo P; Dippenaar R; van Wyk L
Drugs R D; 2020 Jun; 20(2):105-113. PubMed ID: 32266599
[TBL] [Abstract][Full Text] [Related]
22. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease.
Zhao W; Zhang D; Fakhoury M; Fahd M; Duquesne F; Storme T; Baruchel A; Jacqz-Aigrain E
Antimicrob Agents Chemother; 2014 Jun; 58(6):3191-9. PubMed ID: 24663023
[TBL] [Abstract][Full Text] [Related]
24. Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies.
Wang H; Huang L; Wang J; Ni Y; Zhu Z; Gao P; Hu Y; Zhang L; Yang J; Fang L
Pharmacotherapy; 2020 Dec; 40(12):1201-1209. PubMed ID: 33070357
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens.
Hirt D; Oualha M; Pasquiers B; Blanot S; Rubinstazjn R; Glorion C; Messaoudi SE; Drummond D; Lopez V; Toubiana J; Béranger A; Boujaafar S; Zheng Y; Capito C; Winter S; Léger PL; Berthaud R; Gana I; Foissac F; Tréluyer JM; Bouazza N; Benaboud S
Eur J Clin Pharmacol; 2021 Nov; 77(11):1687-1695. PubMed ID: 34160669
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
[TBL] [Abstract][Full Text] [Related]
27. Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance.
Chu Y; Luo Y; Ji S; Jiang M; Zhou B
J Infect Public Health; 2020 Jan; 13(1):68-74. PubMed ID: 31277936
[TBL] [Abstract][Full Text] [Related]
28. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
Lewis SJ; Mueller BA
J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
[TBL] [Abstract][Full Text] [Related]
29. A simple scoring method to predict augmented renal clearance in haematologic malignancies.
Saito K; Kamio S; Ito K; Suzuki N; Abe K; Goto T
J Clin Pharm Ther; 2020 Oct; 45(5):1120-1126. PubMed ID: 32497262
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
Belabbas T; Yamada T; Egashira N; Hirota T; Suetsugu K; Mori Y; Kato K; Akashi K; Ieiri I
J Infect Chemother; 2023 Apr; 29(4):391-400. PubMed ID: 36682608
[TBL] [Abstract][Full Text] [Related]
31. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
Lo YL; van Hasselt JG; Heng SC; Lim CT; Lee TC; Charles BG
Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin population pharmacokinetics analysis in Chinese paediatric patients with varying degrees of renal function and ages: development of new practical dosing recommendations.
Chen J; Huang X; Yu L; Li J; Yang R; Li L; Zhou J; Yao H; Bu S
J Antimicrob Chemother; 2023 Aug; 78(8):2037-2051. PubMed ID: 37379498
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients.
Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E
J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565
[TBL] [Abstract][Full Text] [Related]
34. Initial dosage regimen of vancomycin for septic shock patients: a pharmacokinetic study and Monte Carlo simulation.
Katip Bpharm W; Jaruratanasirikul S; Pattharachayakul S; Wongpoowarak W; Jitsurong A
J Med Assoc Thai; 2014 Nov; 97(11):1209-19. PubMed ID: 25675687
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy.
Li Z; Li H; Wang C; Jiao Z; Xu F; Sun H
BMC Pharmacol Toxicol; 2021 May; 22(1):26. PubMed ID: 33947475
[TBL] [Abstract][Full Text] [Related]
36. Development of a Population Pharmacokinetic Model of Vancomycin and its Application in Chinese Geriatric Patients with Pulmonary Infections.
Zhou Y; Gao F; Chen C; Ma L; Yang T; Liu X; Liu Y; Wang X; Zhao X; Que C; Li S; Lv J; Cui Y; Yang L
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):361-370. PubMed ID: 30506225
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient?
Heffernan AJ; Germano A; Sime FB; Roberts JA; Kimura E
Eur J Clin Pharmacol; 2019 Sep; 75(9):1219-1226. PubMed ID: 31154476
[TBL] [Abstract][Full Text] [Related]
38. Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections.
Lee DH; Kim YK; Jin K; Kang MJ; Joo YD; Kim YW; Moon YS; Shin JG; Kiem S
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223378
[TBL] [Abstract][Full Text] [Related]
39. Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients.
Liu D; Chen W; Wang Q; Li M; Zhang Z; Cui G; Li P; Zhang X; Ma Y; Zhan Q; Wang C
J Clin Pharm Ther; 2020 Oct; 45(5):1066-1075. PubMed ID: 32542736
[TBL] [Abstract][Full Text] [Related]
40. Optimization of Intermittent Vancomycin Dosage Regimens for Thai Critically Ill Population Infected by MRSA in the Era of the "MIC Creep" Phenomenon.
Setiawan E; Suwannoi L; Montakantikul P; Chindavijak B
Acta Med Indones; 2019 Jan; 51(1):10-18. PubMed ID: 31073101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
